Coy Heldermon, M.D., Ph.D., on a phase 1/2 trial design of epidiferphane plus a taxane in breast cancer
In an interview with OncLive, Coy Heldermon, M.D., Ph.D., discusses a trial evaluating epidiferphane given with taxane chemotherapy in breast cancer.